“Differences in the Course of Hepatocellular Carcinoma Depending on the DAA Treatment”. Prospects in Pharmaceutical Sciences 22, no. 3 (August 16, 2024): 114–119. Accessed October 31, 2026. https://prospects.wum.edu.pl/index.php/pps/article/view/236.